DSM-Firmenich presents first H1 results post-merger, negatively impacted by challenging vitamin markets

02 Aug 2023 — Marking a significant milestone in the successful completion of the merger between DSM and Firmenich, the combined company is revealing its half-year results for 2023. The total sales for the first half of the year amounted to €6.15 billion (US$6.76 billion), indicating a 5% decline compared to H1 2022.